Drosophila cancer models 'cancer, epithelial, RAS-SCRIB-related' (FBhh0000585) and 'cancer, epithelial, RAS-LLGL-related' (FBhh0000588) have been used in genetic screens for modulators of tumor growth and invasion. Mutations of two Drosophila Toll receptors, Toll-6 and Toll-7, have been identified in these screens.
Knockdown of Dmel\Toll-6, effected by RNAi and using the RAS-SCRIB model, has minimal effect upon tumor growth but dramatically reduces tumor invasion rate.
Knockdown of Dmel\Toll-7, effected by RNAi and using the RAS-LLGL model, inhibits both tumor growth and tumor invasion rate. Assaying the effect of Toll-7 alone, expression of a constitutively active form of Toll-7 in the wing disc results in tissue overgrowth and a small amount invasive migration.
The roles of Toll-6 and Toll-7 in JNK signaling in the context of cell proliferation and migration have been investigated.
[updated Mar. 2022 by FlyBase; FBrf0222196]
Low-scoring ortholog of human TLR3, TLR7, and TLR9 (multiple related genes in both species).
Low-scoring ortholog of human TLR3, TLR7, and TLR9 (multiple related genes in both species).